In a mouse model of N‐nitrosodiethylamine‐induced HCC, telmisartan can activate PPARγ and regulate the NF‐κB‐TAK1‐ERK1/2 axis, inhibiting tumour proliferation and metastasis.107. The gene discussed is PPARG; the disease is hepatocellular carcinoma.